Category Archives: Healthcare

Verastem (VSTM) Receives a Buy from H.C. Wainwright

H.C. Wainwright analyst Sean Lee CFA maintained a Buy rating on Verastem (VSTM – Research Report) today and set a price target of $5.00. The company’s shares closed last Friday at $2.76. According to TipRanks.com, CFA is a 4-star analyst

Gritstone Oncology (GRTS) Receives a Buy from H.C. Wainwright

H.C. Wainwright analyst Sean Lee CFA maintained a Buy rating on Gritstone Oncology (GRTS – Research Report) today and set a price target of $24.00. The company’s shares closed last Friday at $11.50. According to TipRanks.com, CFA is a 4-star

Analysts Are Bullish on Top Healthcare Stocks: Regeneron (REGN), Protagonist Therapeutics (PTGX)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Regeneron (REGN – Research Report), Protagonist Therapeutics (PTGX – Research Report) and Corcept Therapeutics (CORT – Research Report) with bullish sentiments. Regeneron

Organogenesis Holdings (ORGO) Gets a Buy Rating from Leerink Partners

Leerink Partners analyst Richard Newitter maintained a Buy rating on Organogenesis Holdings (ORGO – Research Report) on September 13. The company’s shares closed last Friday at $16.66. According to TipRanks.com, Newitter is a 5-star analyst with an average return of

Leerink Partners Keeps a Buy Rating on Itamar Medical (ITMR)

Leerink Partners analyst Richard Newitter maintained a Buy rating on Itamar Medical (ITMR – Research Report) on September 13. The company’s shares closed last Friday at $30.30, close to its 52-week high of $30.46. According to TipRanks.com, Newitter is a

Provention Bio (PRVB) Receives a Buy from Leerink Partners

Leerink Partners analyst Thomas Smith maintained a Buy rating on Provention Bio (PRVB – Research Report) on September 13 and set a price target of $16.00. The company’s shares closed last Friday at $6.67, close to its 52-week low of